Federal Register / Vol. 74, No. 109 / Tuesday, June 9, 2009 / Notices 27335 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Cancer 

Diagnostic and Treatment SBIR/STTR. 

Date: June 29–30, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavillion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Bonnie L. Burgess-Beusse, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1783, beusseb@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Competitive 

Revisions; Visual Systems Small Business. 

Date: June 30, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz Carlton Hotel, 1150 22nd Street, 

NW., Washington, DC 20037. 

Contact Person: George Ann McKie, DVM, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1124, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1049, mckiegeo@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Anti-cancer 

Therapy ARRA CR. 

Date: June 30, 2009. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Lawrence Ka-Yun Ng, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutues of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7804, Bethesda, MD 20892, 301–435– 

1719. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 1, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–13428 Filed 6–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Issues in the Design of Clinical Trials 

of Antimycobacterial Drugs for 

Treatment of Tuberculosis; Public 

Workshop 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public workshop. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing a 

public workshop regarding scientific 

issues in clinical trial design for the 

treatment of tuberculosis. This public 

workshop is intended to bring together 

public health experts, health care 

providers, academia, and industry to 

share perspectives on scientific aspects 

of antimicrobial drug development for 

tuberculosis. Topics will include 

considerations in the development of 

clinical trials to study treatments for 

tuberculosis, including enrollment of 

patients, the effect of antimicrobial 

treatment, study endpoints, and 

statistical issues in analysis of results. 

The input from this public workshop 

will help in developing topics for 

further public discussion. 

Date and Time: The public workshop 

will be held on July 30, 2009, from 8 

a.m. to 5:30 p.m. and on July 31, 2009, 

from 8 a.m. to 5 p.m. 

Location: The public workshop will 

be held at the Crowne Plaza Silver 

Spring, 8777 Georgia Ave., Silver 

Spring, MD 20910. Seating is limited 

and available only on a first-come, firstserved basis. 

Contact: Christine Moser or Ramou 

Mauer, Center for Drug Evaluation and 

Research, Food and Drug 

Administration, Office of Antimicrobial 

Products, 10903 New Hampshire Ave., 

Bldg. 22, rm. 6209, Silver Spring, MD 

20993–0002, 301–796–1300. 

Registration: To register 

electronically, e-mail registration 

information (including name, title, firm 

name, address, telephone, and fax 

number) to TBwkshp@fda.hhs.gov by 

July 22, 2009. Persons without access to 

the Internet can call 301–796–1300 to 

register. Registration is free for the 

public workshop. Interested parties are 

encouraged to register early because 

spaced is limited. Seating will be 

available on a first-come, first-served 

basis. Persons needing a sign language 

interpreter or other special 

accommodations should notify 

Christine Moser or Ramou Mauer (see 

Contact) at least 7 days in advance. 

SUPPLEMENTARY INFORMATION: FDA is 

announcing a public workshop 

regarding antimicrobial drug 

development for tuberculosis. This 

public workshop will focus on scientific 

considerations in designing clinical 

trials for tuberculosis. Topics for 

discussion include the enrollment of 

patient populations with tuberculosis, 

the effect size of antimicrobial treatment 

for tuberculosis, assessing effect size of 

a new drug in a multi-drug regimen, 

various endpoints that might be 

considered to assess drug efficacy for 

trials of tuberculosis, the timing of 

assessment for efficacy, extrapolation of 

safety and efficacy to other 

subpopulations, and statistical issues in 

analysis of results from trials in 

tuberculosis. The input from this public 

workshop will help in developing topics 

for further discussion. 

The agency encourages individuals, 

patient advocates, industry, consumer 

groups, health care professionals, 

researchers, and other interested 

persons to attend this public workshop. 

Transcripts: Transcripts of the public 

workshop may be requested in writing 

from the Freedom of Information Office 

(HFI–35), Food and Drug 

Administration, 5600 Fishers Lane, rm. 

6–30, Rockville, MD 20857, 

approximately 20 working days after the 

public workshop, at a cost of 10 cents 

per page. Transcripts will also be 

available on the Internet at http:// 

internet-dev/cder/meeting/tb.htm 

approximately 45 days after the 

workshop. 

Dated: June 2, 2009. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E9–13419 Filed 6–8–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Notice of Meeting; National 

Commission on Children and Disasters 

AGENCY: Administration for Children 

and Families, Department of Health and 

Human Services. 

ACTION: Notice of meeting. 

DATES: The meeting will be held on 

Thursday, June 25, 2009, from 9 a.m. to 

5:30 p.m. 

ADDRESSES: The meeting will be held at 

the Henry J. Kaiser Family Foundation 

Public Affairs Center, 1330 G Street, 

NW., Washington, DC. To attend either 

in person or via teleconference, please 

register by 5 p.m. Eastern Time, June 22, 

2009. To register, please visit http:// 

thenationalacad.disastersroundtable.

sgizmo.com; for information on options 

for remote meeting participation, or if 

you experience technical difficulties, 

please contact Brianna Cash at 

dr@nas.edu or (202) 334–2402. If you 

require a sign language interpreter or 

other special assistance, please call 

Jacqueline Haye at (202) 205–9560 as 

27336 Federal Register / Vol. 74, No. 109 / Tuesday, June 9, 2009 / Notices 

soon as possible and no later than 5 

p.m. Eastern Time, June 11, 2009. 

Agenda: The National Commission on 

Children and Disasters and the National 

Academy of Sciences will co-host a 

workshop entitled ‘‘Children and Youth 

in Disasters: Closing Gaps among 

Research, Practice and Policy.’’ 

Presentations and expert panel 

discussions will: (1) Illuminate pressing 

issues related to disaster preparedness 

and response for children and youth 

and opportunities to reduce their 

vulnerability and increase resiliency in 

disasters; (2) identify and enhance 

opportunities to strengthen connections 

among researchers, practitioners and 

policy makers related to children and 

youth in disasters; (3) discuss concrete 

ideas and actionable suggestions from 

multiple perspectives to apply to policy 

work in this field; and (4) identify 

practical approaches on how the 

country can better prepare to respond to 

children’s needs in disasters. 

Additional Information: Contacts: 

Brianna Cash, The National Academies, 

at dr@nas.edu or (202) 334–2402; 

Vinicia Mascarenhas, National 

Commission on Children and Disasters, 

at vinicia.mascarenhas@acf.hhs.gov or 

(202) 401–9392. 

SUPPLEMENTARY INFORMATION: The 

National Commission on Children and 

Disasters is an independent Commission 

that shall conduct a comprehensive 

study to examine and assess the needs 

of children as they relate to preparation 

for, response to, and recovery from all 

hazards, building upon the evaluations 

of other entities and avoiding 

unnecessary duplication by reviewing 

the findings, conclusions, and 

recommendations of these entities. The 

Commission shall then submit a report 

to the President and the Congress on the 

Commission’s independent and specific 

findings, conclusions, and 

recommendations to address the needs 

of children as they relate to preparation 

for, response to, and recovery from all 

hazards, including major disasters and 

emergencies. 

The National Academy of Sciences is 

an honorific society of distinguished 

scholars engaged in scientific and 

engineering research, dedicated to the 

furtherance of science and technology 

and to their use for the general welfare. 

Dated: June 3, 2009. 

Curtis L. Coy, 

Acting Assistant Secretary for Children and 

Families. 

[FR Doc. E9–13418 Filed 6–8–09; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Addressing 

Emerging Infectious Diseases and 

Related Public Health Threats in the 

People’s Republic of China, Funding 

Opportunity Announcement (FOA), 

GH09–002, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 1 p.m.–4 p.m., June 25, 

2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Addressing Emerging 

Infectious Diseases and Related Public Health 

Threats in the People’s Republic of China, 

FOA GH09–002.’’ 

Contact Person for More Information: 

Shoukat Qari, PhD, Scientific Review 

Administrator, CDC, 1600 Clifton Road, NE., 

Mailstop D72, Atlanta, GA 30333, Telephone 

(404) 639–4663. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: June 2, 2009. 

Lorenzo Falgiano, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E9–13518 Filed 6–8–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, National 

Institute of Mental Health. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Mental Health, 

including consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Institute of Mental 

Health. 

Date: June 22–24, 2009. 

Time: June 22, 2009, 7 p.m. to 10 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Time: June 23, 2009, 8:30 a.m. to 12:40 

p.m. 

Agenda: To review and evaluate the 

Intramural Laboratories with site visits of the 

Emotion and Development Branch, the 

Section on Bipolar Spectrum Disorders, the 

Section on Development and Affective 

Neuroscience, the Section on Behavioral 

Endocrinology, and meetings with PIs, 

Training Fellows, and Staff Clinicians. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Time: June 23, 2009, 12:40 p.m. to 4 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Time: June 23, 2009, 7 p.m. to 10 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Time: June 24, 2009, 8:30 a.m. to 11 a.m. 

Agenda: To review and evaluate the 

Intramural Laboratories with site visits of the 

Laboratory of Behavioral Neuroscience, the 

Section on Neuroanatomy, and meetings with 

the PIs and Training Fellows. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Time: June 24, 2009, 11 a.m. to 1 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Dawn M. Johnson, Ph.D, 

Executive Secretary, Division of Intramural 

Research Programs, National Institute of 

Mental Health, 10 Center Drive, Building 10, 

Room 4N222, Bethesda, MD 20892, 301–402– 

5234, dawnjohnson@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research